Search - tctmd.com

Displaying 1 - 20 of 65

Sort: Relevancy | Date

News Conference News NY Valves 2025

No Benefit of Sentinel Device During TAVI: Updated Meta-analysis

Todd Neale

July 04, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

News Conference News NY Valves 2025

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE

Todd Neale

June 27, 2025

Presentation NY Valves 2025

One Year Results of a Clinical Study Using a Novel Polymeric Valve for Surgical Mitral Valve Replacement

Presenter: Isaac George

June 27, 2025

Presentation NY Valves 2025

Global and Regional Burden of Non-Rheumatic Degenerative Mitral Valve Disease: Implications for Transcatheter Therapies

Presenter: Guido Ascione

June 27, 2025

Presentation NY Valves 2025

Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry

Presenter: Santiago Garcia

June 27, 2025

Presentation NY Valves 2025

Two-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study

Presenter: Gilbert H. L. Tang

June 27, 2025

Presentation NY Valves 2025

Innovations in Pharmacotherapy – Focus on Factor XI Inhibitors

Presenter: Roxana Mehran

June 26, 2025

Presentation NY Valves 2025

Next Generation LAAC Device Development

Presenter: Horst Sievert

June 26, 2025

Presentation NY Valves 2025

Conformal

Presenter: Shephal K. Doshi

June 26, 2025

Presentation NY Valves 2025

AMULET NG

Presenter: Devi G. Nair

June 26, 2025

Presentation NY Valves 2025

Current Trials to Expand LAAC Clinical Indications

Presenter: Vivek Y. Reddy

June 26, 2025

Presentation NY Valves 2025

Prognostic Impact of Extra-Tricuspid Valve Involvement After Tricuspid Transcatheter Edge-to-Edge Repair: Insights from the Bronx Valve and TRISPA Registries

Presenter: Julio Echarte Morales

June 26, 2025

Presentation NY Valves 2025

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

Presenter: Suzanne V. Arnold

June 26, 2025

Presentation NY Valves 2025

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Presenter: Paul A. Grayburn

June 26, 2025

Presentation NY Valves 2025

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

Presenter: Matthew J. Price

June 26, 2025

Presentation NY Valves 2025

What Are the Next Clinical Trials Needed in the Tricuspid Space?

Presenter: David J. Cohen

June 26, 2025

Presentation NY Valves 2025

MAYBE, Lets Also Consider the OUS Registry Data

Presenter: Ralph Stephan von Bardeleben

June 26, 2025

Presentation NY Valves 2025

NO, Unblinded Patient-Reported Outcomes Are Simply Not Enough!

Presenter: Sanjay Kaul

June 26, 2025

Presentation NY Valves 2025

YES, in these Desperate Patients, Quality-of-Life Outcomes Are a Great Starting Point!

Presenter: Paul Sorajja

June 26, 2025

Advertisement

No Benefit of Sentinel Device During TAVI: Updated Meta-analysis

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE

One Year Results of a Clinical Study Using a Novel Polymeric Valve for Surgical Mitral Valve Replacement

Global and Regional Burden of Non-Rheumatic Degenerative Mitral Valve Disease: Implications for Transcatheter Therapies

Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry

Two-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study

Innovations in Pharmacotherapy – Focus on Factor XI Inhibitors

Next Generation LAAC Device Development

Conformal

AMULET NG

Current Trials to Expand LAAC Clinical Indications

Prognostic Impact of Extra-Tricuspid Valve Involvement After Tricuspid Transcatheter Edge-to-Edge Repair: Insights from the Bronx Valve and TRISPA Registries

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

What Are the Next Clinical Trials Needed in the Tricuspid Space?

MAYBE, Lets Also Consider the OUS Registry Data

NO, Unblinded Patient-Reported Outcomes Are Simply Not Enough!

YES, in these Desperate Patients, Quality-of-Life Outcomes Are a Great Starting Point!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content